[TCTAP Workshops] TAVR: Key Issues in 2025

April 24, 2025 / 8:10 AM ~ 9:50 AM 📌 Valve & Endovascular Theater, Level 1

  • May 09, 2025
  • 54
Moderator(s): Eberhard Grube, Martin Bert Leon
Panelist(s): Wacin Buddhari, Junbo Ge, Philippe Genereux, Juan F. Granada, Byung-Hee Hwang, Hyo-Soo Kim, Alexandra J. Lansky, Karl Poon, Jian'an Wang

  • Innovation in TAVR- What Can We Expect for the Next Decade?
    Martin Bert Leon
  • TAVR for Asymptomatic Severe AS: The EARLY TAVR Trial
    Philippe Genereux
  • TAVR for Moderate AS and Heart Failure: The TAVR UNLOAD Trial
    David Joel Cohen
  • Updated Approval RCTs for Novel TAVR Devices: The ACURATE IDE Trial and More
    Philippe Garot
  • Panel Discussion I
  • MRI Surrogate Endpoints in TAVR Trials: Is It Clinically Relevant?
    Alexandra J. Lansky
  • Non-Femoral TAVR Approach: What Are Best?
    Ho Jin Kim
  • Redo-TAVR From Planning to Execution: Tips and Tricks
    Gilbert H. L. Tang
  • Contemporary Optimal Antiplatelet Therapy in TAVR: No More Debates?
    Duk-Woo Park
  • Panel Discussion II

Debate 2025: Use of Cerebral Embolic Protection in Contemporary TAVR Practice

  • Yes: We Have Strong Evidence
    Philippe Genereux
  • Not Yet: Futility for Stroke Events
    David Joel Cohen
  • Panel Discussion III
Share this Post:
Video List